Status:
UNKNOWN
Acupuncture for Irritable Bowel Syndrome Patients
Lead Sponsor:
Hong Kong Baptist University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, a 14-week, single blinded, randomized controlled clinical trial will be conducted to determine whether acupuncture could have significant benefits than sham acupuncture for IBS.
Detailed Description
This is a single blinded randomized sham controlled clinical trial with two arms. 120 IBS patients will be recruited. The study will cooperate with Hong Kong Baptist University, and University of Toro...
Eligibility Criteria
Inclusion
- Fulfillment of the Rome IV criteria for IBS
- IBS Symptom Severity Scale (IBS-SSS) \> 75 points (a range of 0-500 points of VAS on five questions) at baseline and during the 2-week run-in period
- Written informed consent.
Exclusion
- Pregnancy or breast-feeding
- Medical history of inflammatory bowel diseases, carbohydrate malabsorption, hormonal disorder, known allergies to food additives, and/or any other serious diseases
- Unstable medical conditions
- Unstable mental condition or with history of mental illness
- Patients who have received acupuncture treatment in last three months, or took concomitant medication with affect gastrointestinal motility or visceral sensation, such as antidiarrheal agent, antidepressant, narcotic analgesic, and anticholinergic
- Alcoholism or drug abuse in past 1 year
- Having needle phobia
Key Trial Info
Start Date :
May 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04387383
Start Date
May 18 2020
End Date
December 1 2021
Last Update
July 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linda Zhong
Kowloon Tong, Kowloon, Hong Kong